Incidence of symptomatic toxoplasma eve disease: Aetiology and public health implications

Epidemiology and Infection

Volumn 123, Issue 2, 1999, Pages 283-289

  Gilbert, R E ^a   Dunn, D T ^a   Lightman, S ^b   Murray, P I ^c   Pavesio, C E ^b   Gormley, P D ^b   Masters, J ^a   Parker, S P ^a   Stanford, M R ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CHILD; CONGENITAL TOXOPLASMOSIS; EYE DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PRENATAL SCREENING; PRIMARY PREVENTION; RISK; SCREENING; TOXOPLASMOSIS; UNITED KINGDOM; VISUAL ACUITY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PUBLIC HEALTH; RISK; TOXOPLASMOSIS, OCULAR;

EID: 0032728720     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899002800     Document Type: Article

References (34)

1. Petithory JC, Garin JP, Milgram M. Serologie de la toxoplasmose. Aspect actuels a travers le controle de qualite nationel en parasitologie en France. In: Anonymous Formation continue conventionelle des Directeurs de Laboratoires Prives d'Analyses de Biologie Medicale, 1992. Paris: Bioforma, 1993: 25-51.
2. Lebech M, Andersen O, Christensen N, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999; 353: 1834-7.
3. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994; 330: 1858-63.
4. Scaravelli G, Thorne C, Newell M-L. The management of pregnancy and delivery in HIV infected women in Europe. Eur J Obstet Gynaec Reprod Biol 1995; 62: 7-13.
5. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis Suppl 1992; 84: 43-5.
6. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 1992; 84: 32-7.
7. Koppe JG, Loewer Sieger DH, de Roever Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1986; i: 254-6.
8. Conyn-van-Spaedonck MAE. Prevention of congenital toxoplasmosis in the Netherlands. (Thesis). National Institute of Public Health and Environmental Protection 1991; ISBN 90-9004179-6.
9. Lappalainen M, Koskiniemi M, Hiilesmaa V, et al. Outcome of children after maternal primary toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995; 14: 354-61.
10. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973; 57: 1-17.
11. O'Connor GR. Toxoplasma: In: Tasman W, Jaeger EA, eds. Duane's biomedical foundation of ophthalmology, Philadelphia: Harper and Row, 1987: 1-14.
12. Dubey JP. Toxoplasmosis in man. In: Dubey JP, Beattie C, eds. Toxoplasmosis in animals and man, 1st ed. Boca Raton, Florida: CRC Press, 1988: 41-59.
13. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein J, eds, 4th ed. Infectious diseases of the fetus and newborn. Pennsylvania: WB Saunders, 1995: 140-267.
14. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol 1993; 77: 371-7.
15. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969; 81: 481-93.
16. Multidisciplinary Working Group. Prenatal screening for toxoplasmosis in the UK. London: Royal College of Obstetricians and Gynaecologists, 1992.
17. Cubitt WD, Ades AE, Peckham CS. Evaluation of five commercial assays for screening antenatal sera for antibodies to Toxoplasma gondii. J Clin Pathol 1992; 45: 435-8.
18. Duffy KT, Wharton PJ, Johnson JD, New L, Holliman RE. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol 1989; 42: 1291-5.
19. Breslow NE, Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. Lyon: IARC Scientific Publications, 1987: 57-9.
20. Wilson J, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation, 1968. (Public Health Papers No. 34).
21. Ades AE, Nokes DJ. Modeling age-and time-specific incidence from seroprevalence: toxoplasmosis. Am J Epidemiol 1993; 137: 1022-34.
22. Ades AE, Parker S, Gilbert RE, et al. Maternal prevalence of toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis. Epidemiol Infect 1993; 110: 127-33.
23. Allain JP, Palmer CR, Pearson G. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK. J Infect 1998; 36: 189-96.
24. Lynn R, Hall SM. The British Paediatric Surveillance Unit: activities and developments in 1990 and 1991. CDR Rev 1992; 2: R145-8.
25. Rahi J, Dezateux C. Epidemiology of visual impairment in Britain. Arch Dis Child 1998; 78: 381-6.
26. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ 1995; 310: 1037-40.
27. Roizen N, Swisher CN, Stein MA et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995; 95: 11-20.
28. Hall SM. Congenital toxoplasmosis. BMJ 1992; 305: 291-7.
29. Sibalic D, Djurkovic Djakovic O, Bobic B. Onset of ocular complications in congenital toxoplasmosis associated with immunoglobulin M antibodies to Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 1990; 9: 671-4.
30. Walker J, Nokes DJ, Jennings R. Longitudinal study of toxoplasma seroprevalence in South Yorkshire. Epidemiol Infect 1992; 108: 99-106.
31. Burnett A, Shortt S, Isaac-Renton J, King A, Werker D, Bowie WR. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998; 105: 1032-7.
32. Perkins ES. Epidemiology of uveitis. Trans Ophthalmol Soc UK 1976; 96: 105-7.
33. Olurin O, Fleck DG, Osuntokun B. Toxoplasmosis and chorioretinitis in Nigeria. Trop Geogr Med 1972; 24: 240-5.
34. Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, west Africa. Br J Ophthalmol 1996; 80: 956-61.